As of 2025-10-16, the Relative Valuation of Landos Biopharma Inc (LABP) is (99.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -531.9%.
The range of the Relative Valuation is (72.09) - (101.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 12.8x | 10.0x |
| Forward P/E multiples | 9.1x - 17.7x | 15.0x |
| Fair Price | (72.09) - (101.72) | (99.03) |
| Upside | -414.4% - -543.6% | -531.9% |
| Date | P/E |